ARCHIVES

Iniparib Plus Chemo Shows Benefit In Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020

January 28, 2011

In Brief: Judge Declines To Block NCI Contract Award

February 24, 1995

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

In Brief: Wilson Names Director, MCW cancer Center; UAB Cancer Center Makes Three Appointments

February 9, 1996